Basics Crinetics Pharmaceuticals, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $5.68B Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 2.68% Avg Daily Range (30 D): $1.18 | 2.35% Avg Daily Range (90 D): $1.05 | 2.39% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): 1M Avg Daily Volume (90 D): 1.14M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 2,706 Avg Inst. Trade: $2.83M Avg Inst. Trade (30 D): $5.08M Avg Inst. Trade (90 D): $6.18M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.43M Avg Closing Trade (30 D): $13.45M Avg Closing Trade (90 D): $12.73M Avg Closing Volume: 124.12K     News Jan 4, 2026 @ 9:00 PM Crinetics Pharmaceuticals to Provide PALSONIFY Bus... Source: Na Dec 3, 2025 @ 1:00 PM Crinetics Announces First Patient Dosed in Phase 1... Source: Crinetics Pharmaceuticals Nov 7, 2025 @ 9:16 PM Why Crinetics Pharmaceuticals Stock Was Sliding on... Source: Eric Volkman Oct 10, 2025 @ 8:41 PM Crinetics Pharmaceuticals Announces October 2025 I... Source: Crinetics Pharmaceuticals Sep 28, 2025 @ 12:30 PM Is Crinetics Pharmaceuticals Stock a Buy? Source: George Budwell Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.38 $-1.23 Diluted EPS $-1.38 $-1.23 Revenue $ $ .14M $ 1.03M Gross Profit $ $ $ Net Income / Loss $ $ -130.09M $ -115.64M Operating Income / Loss $ $ -142.59M $ -129.11M Cost of Revenue $ $ $ Net Cash Flow $ $ 57.18M $ -40.84M PE Ratio